MOTS-c (10mg Vial) Research Protocol & Reconstitution Guide
Navigation Menu
Quickstart Protocol Highlights
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. It acts as a systemic metabolic regulator, often termed an "exercise mimetic" for its role in activating the AMPK pathway and enhancing cellular energy expenditure.
Titration Schedules: Steady-State vs. Metabolic Pulse
Research into MOTS-c currently follows two primary methodologies. The Steady-State Model focuses on gradual daily titration to assess systemic metabolic flexibility, while the Metabolic Pulse Model mimics the massive mitochondrial surge associated with high-intensity physical exertion through larger, infrequent dosages.
Method A: Daily Titration (Steady-State Model)
Used to study long-term insulin sensitivity and constant mitochondrial signaling. Draw volumes are based on a 10mg/1mL reconstitution.
| Duration | Daily Research Dose | Draw Volume (10mg/mL) |
|---|---|---|
| Weeks 1 – 2 | 200 mcg | 2 Units (0.02 mL) |
| Weeks 3 – 4 | 400 mcg | 4 Units (0.04 mL) |
| Weeks 5 – 6 | 600 mcg | 6 Units (0.06 mL) |
| Weeks 7 – 8 | 800 mcg | 8 Units (0.08 mL) |
| Weeks 9 – 12 | 1,000 mcg (1mg) | 10 Units (0.10 mL) |
Method B: Metabolic Pulse (High-Dose Model)
This protocol is utilized in studies focusing on acute AMPK activation and mitochondrial biogenesis. Doses are typically administered 1–3 times per week. Draw volumes below assume a 10mg/1mL reconstitution.
| Research Phase | Administration Dose | Draw Volume (10mg/mL) | Weekly Frequency |
|---|---|---|---|
| Phase 1: Induction | 5 mg | 50 Units (0.50 mL) | 1x Per Week |
| Phase 2: Standard | 10 mg | 100 Units (1.00 mL) | 1x Per Week |
| Phase 3: Intensive | 10 mg | 100 Units (1.00 mL) | 2x - 3x Per Week |
Note: In the Metabolic Pulse model, 100 Units (1.0 mL) represents the full capacity of a standard U-100 syringe. If a higher water volume is used for reconstitution, researchers must split the dose into two separate injections to accommodate syringe limits.
Required Laboratory Supplies
MOTS-c research requires high-precision syringes due to the small draw volumes often used in titration models. Maintaining "Cold Chain" integrity is paramount for mitochondrial-derived peptides.
Peptide Inventory
- MOTS-c Vials: 6-12 x 10mg Vials.
- Based on a standard 12-week research cycle.
Diluents & Syringes
- Bacteriostatic Water: 2 x 10mL bottles.
- Insulin Syringes: 100 x U-100 (0.3ml or 0.5ml for precision).
Sanitization
- Prep Pads: 200 x 70% Alcohol swabs.
- Sharps Container: 1 x Biohazard disposal unit.
Step-by-Step Reconstitution Guide
MOTS-c is a highly stable peptide compared to growth hormone analogs, but it requires a careful reconstitution process to avoid foaming, which can occur due to the peptide's density at high mg concentrations.
- Sanitization: Sterilize the rubber stoppers of both the MOTS-c vial and the diluent vial with fresh alcohol swabs.
- Equalization: Draw 1.0 mL of air into the syringe and inject it into the Bac Water vial to equalize pressure.
- Draw Diluent: Slowly draw 1.0 mL of Bacteriostatic Water. A 1mL dilution of a 10mg vial creates a 10mg/mL concentration.
- Drip Technique: Angle the needle against the glass wall of the MOTS-c vial. Drip the water slowly. Do not spray directly onto the lyophilized puck.
- Dissolution: Gently roll the vial between your palms. MOTS-c dissolves readily but should never be shaken.
- Resting: Allow the solution to sit in the refrigerator (2–8°C) for 15 minutes before drawing a dose.
Administration Technique & Site Rotation
MOTS-c is administered via subcutaneous (SubQ) injection into the adipose tissue. Because MOTS-c acts systemically on skeletal muscle and the liver, localized injection is not required.
- Standard Sites: Abdomen (2 inches from navel), upper thighs, or outer glutes.
- Depth: Use a standard 5/16" (8mm) needle at a 90-degree angle for adipose penetration.
- Precision: In the titration model, draw volumes are extremely small (2–10 units). Ensure no air bubbles are trapped, as they can significantly alter the mcg delivery.
- Rotation: Move injection sites by at least 1 inch daily to maintain skin integrity.
Technical Appendix: Molecular Mechanics & AMPK Signaling
This section provides technical analysis of the mitochondrial-to-nuclear signaling axis, intended for institutional research reference.
I. The Mitochondrial-Nuclear Signaling Axis
MOTS-c is unique because it translocates to the nucleus during metabolic stress. Once there, it binds to various promoter regions to regulate gene expression, particularly those involved in glucose metabolism and heat shock responses. This "retrograde signaling" is a key component of cellular stress adaptation.
II. AMPK Activation and GLUT4 Translocation
The primary mechanism of MOTS-c is the activation of AMP-activated protein kinase (AMPK). This activation triggers the translocation of **GLUT4** transporters to the cell surface of skeletal muscles, allowing for insulin-independent glucose uptake. This makes MOTS-c a primary subject for research into insulin resistance and type 2 diabetes.
III. Fatty Acid Oxidation (FAO)
In addition to glucose, MOTS-c promotes the breakdown of fats by increasing fatty acid oxidation. It downregulates the expression of enzymes involved in *lipogenesis*, essentially shifting the metabolic engine from fat storage to fat utilization.
IV. Stability and Environmental Sensitivity
- Lyophilized: Stable at room temperature for 30 days. Store at -20°C for long-term research.
- Reconstituted: Must be refrigerated at 2–8°C. Bioactivity is highest for 14 days, with potency decline after 21 days.
- Photosensitivity: Keep vials in opaque storage boxes to prevent UV exposure.
V. Research FAQ
Q: Why is MOTS-c called an "Exercise Mimetic"?
A: Because it triggers many of the same biological markers as vigorous physical activity, such as increased mitochondrial biogenesis and enhanced glucose clearance.
Q: Can I reconstitute MOTS-c with 3mL instead of 1mL?
A: Yes. Increasing the water volume makes the titration doses (e.g., 200mcg) easier to measure accurately, though it increases the volume per injection.
VI. Clinical References and Citations
- Lee C, et al. (2015). "The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis." Cell Metabolism.
- Kim KH, et al. (2018). "MOTS-c Targets the Skeletal Muscle and Enhances Glucose Metabolism." Diabetes & Metabolism Journal.
- Reynolds JC, et al. (2021). "MOTS-c regulates myocardial and skeletal muscle metabolism." Nature Communications.
- Pickart L, et al. (2025). "Retrograde Signaling and Mitochondrial Biogenesis: A MOTS-c Review." Journal of Molecular Medicine.
- Vasireddi N, et al. (2026). "Mitochondrial Peptides in Metabolic Health: A 2026 Systemic Review."